News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
237,169 Results
Type
Article (11483)
Company Profile (29)
Press Release (225657)
Section
Business (76250)
Career Advice (1063)
Deals (14500)
Drug Delivery (33)
Drug Development (35176)
Employer Resources (38)
FDA (6045)
Job Trends (5799)
News (129268)
Policy (9640)
Tag
Academia (753)
Alliances (10271)
Alzheimer's disease (567)
Approvals (6086)
Artificial intelligence (99)
Bankruptcy (95)
Best Places to Work (5210)
Breast cancer (158)
Cancer (1121)
Cardiovascular disease (70)
Career advice (839)
CAR-T (60)
Cell therapy (182)
Clinical research (29981)
Collaboration (337)
Compensation (370)
COVID-19 (944)
C-suite (57)
Data (1108)
Diabetes (125)
Diagnostics (2310)
Earnings (54881)
Events (37806)
Executive appointments (265)
FDA (6567)
Funding (317)
Gene therapy (131)
GLP-1 (343)
Government (1387)
Healthcare (7319)
Infectious disease (998)
Inflammatory bowel disease (60)
Interviews (192)
IPO (9213)
Job creations (968)
Job search strategy (743)
Layoffs (149)
Legal (1712)
Lung cancer (178)
Lymphoma (86)
Manufacturing (100)
Medical device (5098)
Medtech (5098)
Mergers & acquisitions (5605)
Metabolic disorders (320)
Neuroscience (778)
NextGen: Class of 2025 (2243)
Non-profit (1474)
Northern California (1273)
Obesity (168)
Opinion (65)
Parkinson's disease (58)
People (9359)
Phase I (8176)
Phase II (12878)
Phase III (11357)
Pipeline (549)
Postmarket research (1267)
Preclinical (2716)
Radiopharmaceuticals (118)
Rare diseases (155)
Real estate (1147)
Regulatory (7335)
Research institute (724)
Resumes & cover letters (197)
Southern California (1066)
Startups (792)
United States (10067)
Vaccines (294)
Weight loss (112)
Date
Today (5)
Last 7 days (378)
Last 30 days (1556)
Last 365 days (18967)
2025 (2802)
2024 (18408)
2023 (17837)
2022 (21574)
2021 (22719)
2020 (20351)
2019 (17975)
2018 (12805)
2017 (12137)
2016 (10390)
2015 (12659)
2014 (9071)
2013 (6615)
2012 (7212)
2011 (7510)
2010 (6715)
Location
Africa (278)
Asia (14347)
Australia (2202)
California (2842)
Canada (863)
China (228)
Colorado (124)
Connecticut (141)
Delaware (88)
Europe (33626)
Florida (357)
Georgia (76)
Illinois (236)
Indiana (128)
Japan (90)
Maryland (359)
Massachusetts (2101)
Michigan (73)
Minnesota (150)
New Jersey (766)
New York (747)
North Carolina (351)
Northern California (1273)
Ohio (81)
Pennsylvania (542)
South America (428)
Southern California (1066)
Texas (407)
Utah (58)
Washington State (274)
237,169 Results for "4".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
Bonus Episode: Q4 2024 Job Market Update
In this bonus episode,
BioSpace’s
vice president of marketing
Chantal Dresner
and careers editor
Angela Gabriel
take a look at Q4 job market performance and what we expect to see ahead.
January 21, 2025
·
1 min read
·
Angela Gabriel
Layoffs
X4 Pharmaceuticals Stumbles Again, Laying Off 30% of Workforce
The headcount reduction will save money that the company will use in developing mavorixafor, its CXCR4 antagonist that last year received FDA approval to treat WHIM syndrome, in the larger patient population with chronic neutropenia.
February 6, 2025
·
1 min read
·
Dan Samorodnitsky
Podcast
RFK Jr. Advances, Q4 Earnings Roll Out and a Non-Opioid Pain Drug Hits the Market
Robert F. Kennedy Jr.’s HHS nomination moves to a full Senate vote; Donald Trump’s tariff war sparks China-related concerns for biopharma; Pfizer, Merck and more announce Q4 and 2024 earnings; and the non-opioid painkiller space heats up as FDA approves Vertex’s Jounavx.
February 5, 2025
·
1 min read
·
Heather McKenzie
Press Releases
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 4, 2025
February 5, 2025
·
1 min read
Press Releases
4DMT Focuses Pipeline to Prioritize 4D-150 in Wet AMD & DME and 4D-710 in CF and Extends Cash Runway
January 13, 2025
·
9 min read
Press Releases
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 4, 2025
February 5, 2025
·
4 min read
Press Releases
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 4, 2025
February 5, 2025
·
5 min read
Press Releases
Alpha-1 Antitrypsin Deficiency Market Size to Reach USD 4.4 Million by 2035, Impelled by Increasing Awareness and Diagnosis Rates
February 20, 2025
·
10 min read
Press Releases
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 4, 2025
February 5, 2025
·
1 min read
Press Releases
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 4, 2025
February 5, 2025
·
1 min read
1 of 23,717
Next
